207940.KS
Samsung Biologics Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 1,396,000.00
−0.92%Forward multiples
Based on analyst estimates
- P/E forward
- 30.66x
- P/E 2026E
- 33.84x
- P/E 2027E
- 28.53x
- P/E 2028E
- 25.43x
- P/S forward
- 10.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.55x
- PEG TTM
- 5.29x
- Price / book
- 7.72x
- Price / sales
- 14.20x
- Price / cash flow
- 26.52x
Enterprise value
- Enterprise value
- KRW 63.60T
- EV / sales
- 13.99x
- EV / EBITDA
- 21.53x
- EV / EBIT
- 32.01x
- Market cap
- KRW 64.55T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026